Wegovy’s arrival provides Ozempic alternative for weight management

Supplies of Ozempic (semaglutide) should be prioritised for type 2 diabetes patients the TGA says, as sponsor Novo Nordisk, launches its Wegovy brand for weight loss  Pharmacists and prescribers are being advised to consider if patients prescribed Ozempic for off-label use “can be changed to an alternative treatment such as Wegovy”, to perserve supplies of